Perea A E, Hinckley A F, Mead P S
Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Zoonoses Public Health. 2015 Aug;62(5):388-92. doi: 10.1111/zph.12159. Epub 2014 Sep 22.
In a recent national survey, over 30% of healthcare providers (HCPs) reported prescribing tick bite prophylaxis in the previous year. To clarify provider practices, we surveyed HCPs to determine how frequently and for what reasons they prescribed tick bite prophylaxis. We included four questions regarding tick bite prophylaxis in the DocStyles 2012 survey, a computer-administered questionnaire of 2205 US primary care physicians, paediatricians and nurse practitioners. Responses in 14 states with high Lyme disease incidence (high LDI) were compared with responses from other states (low LDI). Overall, 56.4% of 1485 providers reported prescribing tick bite prophylaxis at least once in the previous year, including 73.9% of HCPs in high LDI and 48.2% in low LDI states. The reasons given were 'to prevent Lyme disease' (76.9%), 'patients request it' (40.4%) and 'to prevent other tickborne diseases' (29.4%). Among HCPs who provided prophylaxis, 45.2% did so despite feeling that it was not indicated. Given a hypothetical scenario involving a patient with an attached tick, 38.1% of HCPs from high LDI states and 15.1% from low LDI states would prescribe a single dose of doxycycline; 19.0% from high LDI states and 27.5% from low LDI states would prescribe a full course of doxycycline. HCPs prescribe tick bite prophylaxis frequently in areas where Lyme disease is rare and for tickborne diseases for which it has not been shown effective. HCPs may be unaware of current tick bite prophylaxis guidelines or find them difficult to implement. More information is needed regarding the efficacy of tick bite prophylaxis for diseases other than Lyme disease.
在最近的一项全国性调查中,超过30%的医疗服务提供者(HCPs)报告称在前一年曾开具蜱虫叮咬预防药物。为了明确医疗服务提供者的做法,我们对HCPs进行了调查,以确定他们开具蜱虫叮咬预防药物的频率以及原因。在2012年DocStyles调查中,我们纳入了四个关于蜱虫叮咬预防的问题,该调查是一份由计算机管理的问卷,面向2205名美国初级保健医生、儿科医生和执业护士。将莱姆病发病率高的14个州(高LDI)的回答与其他州(低LDI)的回答进行了比较。总体而言,1485名医疗服务提供者中有56.4%报告称在前一年至少开具过一次蜱虫叮咬预防药物,其中高LDI州的HCPs中有73.9%,低LDI州的有48.2%。给出的理由包括“预防莱姆病”(76.9%)、“患者要求”(40.4%)以及“预防其他蜱传疾病”(29.4%)。在提供预防措施的HCPs中,45.2%的人尽管觉得没有必要,但还是这样做了。针对一个涉及蜱虫附着在患者身上的假设情景,高LDI州的HCPs中有38.1%会开具单剂量强力霉素,低LDI州的有15.1%;高LDI州的19.0%和低LDI州的27.5%会开具一个疗程的强力霉素。在莱姆病罕见的地区,HCPs经常为蜱传疾病开具蜱虫叮咬预防药物,而这些药物对这些疾病并未显示出有效性。HCPs可能不了解当前的蜱虫叮咬预防指南,或者觉得难以实施这些指南。关于蜱虫叮咬预防对莱姆病以外疾病的疗效,还需要更多信息。